Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
Medical University of Vienna
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
Massachusetts General Hospital
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
Sunstone Medical
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
Erin Kirkham
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
Medical University of Vienna
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Madeline Fields
Ketamine Treatment of Youth Suicide Attempters
Tatiana Falcone, MD
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
University Health Network, Toronto
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
Loyola University
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Johns Hopkins University
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
Natalie Lockney
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
University of Milano Bicocca
Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC
University of Crete
Ketamine in Acute Brain Injury Patients.
Geert Meyfroidt, MD, PhD
Long-term Observation of Participants With Mood Disorders
National Institute of Mental Health (NIMH)
Understanding Ketamine's Dissociative Effects (KD Study)
Stanford University
Ketamine Assisted Psychotherapy for Opioid Use Disorder
University of Utah
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Johns Hopkins University
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
University of Wisconsin, Madison
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
Sam Tyagi
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
University of Florida
University of Iowa Interventional Psychiatry Service Patient Registry
Mark Niciu
Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair
University of Crete
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
University of Oklahoma
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
Naveen Poonai
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
National Institute of Mental Health (NIMH)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
Göteborg University
Premedication for Less Invasive Surfactant Administration
University of Oulu
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
University Hospital, Basel, Switzerland
Anesthetics and Analgesics in Children
Chi Dang Hornik
Measuring Analgesic Interventions
Julia Finkel
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Salem Anaesthesia Pain Clinic
Dexmedetomidine and Ketamine in VATS Surgery
Ciusss de L'Est de l'Île de Montréal
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
University of Saskatchewan
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
National Institute of Mental Health (NIMH)
The Neurobiological Effect of 5-HT2AR Modulation
Gitte Moos Knudsen
Neurobiology of Suicide
National Institute of Mental Health (NIMH)
Ketamine Alcohol (in Treatment-Resistant Depression)
Mark Niciu
National Pregnancy Registry for Psychiatric Medications
Massachusetts General Hospital
Safety Profile of Psilocybin for Cocaine Use Disorder
University of California, Los Angeles
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Global Coalition for Adaptive Research
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)
University of Wisconsin, Madison
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
Grace Lim, MD, MS
Ketamine for Sedation in Severe Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Nova Mentis Life Science Corp
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.